financetom
Market
financetom
/
Market
/
India's midcap index can gain another 13%, says CLSA
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
India's midcap index can gain another 13%, says CLSA
Jun 12, 2023 7:45 AM

The positive outlook and the possibility of a 13 percent to 24 percent increase make midcap stocks an attractive option for those seeking substantial returns on their investments, feel market experts. CLSA analyst Laurence Balanco on Monday advised investors to focus on midcap stocks for potential outperformance citing the current market conditions and the breakout in the midcap segment.

Share Market Live

NSE

From COVID-19 lows, FY21 was the year for large caps. However, FY22 saw strong earnings per share (EPS) growth from the midcap space. In FY23, earnings spread over the largecap and midcap have been maintained. Lately, the Nifty Midcap 100 index has performed decently as well. The category witnessed a rise of 6.5 percent in May amid improvement in returns of midcap stocks. In FY23, the category rose by 1.15 percent. Categories like midcap IT, new-age tech, hospitals, midcap banks and luxury consumption categories, including hotels, have done very well.

Balanco has made a bold prediction regarding the midcap index, foreseeing a significant upswing in the coming months. Balanco believes that the midcap index holds immense potential for growth, projecting a 13 percent increase in value initially, with the possibility of a remarkable 24 percent surge. This breakout in the broader market is an essential development that investors should take note of.

“We think at the moment, we have got 13 percent upside but we have upside target extending towards 24 percent, so that is an important breakout that we have seen in the broader market,” he said.

This breakout from the 18-month consolidation pattern is a significant milestone for the midcap segment, positioning it as a leader in the Indian market and offering potential outperformance opportunities for investors.

When assessing the midcap index in relation to the top 50 stocks, an interesting development comes to light. Balanco pointed out that the midcap index has experienced a breakout in relative price action after an 18-month consolidation pattern. This breakout indicates a shift in market dynamics, with midcaps taking the lead in driving the Indian market towards upward momentum.

“Then if you are looking at the midcap index relative to the top-50 stocks, you have seen that relative price action breakout of a 18 month consolidation pattern, so basically it has the midcaps as the leading part of the Indian market to the upside and that is where we think investors should focus for outperformance going forward,” he mentioned.

While midcaps have been displaying remarkable strength, Balanco also believes that the Nifty, the benchmark index of the Indian stock market, might face challenges in surpassing the 18,800 mark. The Nifty's recent performance has shown signs of consolidation, as it attempts to break through this critical resistance level. Balanco's observation suggests that the broader market could experience a period of consolidation as it grapples with this key hurdle.

Over the past two months, the midcap index has witnessed an impressive surge of 17 percent, outperforming the Nifty, which recorded comparatively modest gains. Simultaneously, the smallcap index experienced an even more substantial rise of 20 percent, indicating a broad-based rally across various market segments.

The significant outperformance of midcaps and smallcaps compared to the Nifty highlights a shift in investor sentiment towards broader market participation. This indicates a growing appetite for riskier assets and a belief in the potential of smaller companies to generate higher returns.

For more details, watch the accompanying video

Catch all the latest updates from the stock market here

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Equity Markets Close Mixed Ahead of Fed Decision
Equity Markets Close Mixed Ahead of Fed Decision
Jul 30, 2024
04:30 PM EDT, 07/30/2024 (MT Newswires) -- US benchmark equity indexes closed mixed Tuesday as the Federal Reserve kicked off its two-day monetary policy meeting, with a decision on interest rates expected Wednesday. The Nasdaq Composite dropped 1.3% to 17,147.4, while the S&P 500 fell 0.5% to 5,436.4. The Dow Jones Industrial Average rose 0.5% to 40,743.3. Technology saw the...
CGI's U.S. Unit to Acquire Aeyon for an Undisclosed Price to Boost its AI Offerings for the U.S. Government
CGI's U.S. Unit to Acquire Aeyon for an Undisclosed Price to Boost its AI Offerings for the U.S. Government
Jul 30, 2024
04:54 PM EDT, 07/30/2024 (MT Newswires) -- CGI (GIB-A.TO, GIB) on Tuesday said CGI Federal, its U.S. unit, agreed to acquire Aeyon, which provides artificial-intelligence services to the U.S. government, for an undisclosed price. CGI, a global IT and business consulting services firm, said the two companies entered into a definitive purchase agreement on June 22 and the acquisition is...
Sector Update: Energy
Sector Update: Energy
Jul 30, 2024
03:34 PM EDT, 07/30/2024 (MT Newswires) -- Energy stocks were higher late Tuesday afternoon, with the NYSE Energy Sector Index adding 0.8% and the Energy Select Sector SPDR Fund (XLE) climbing 1.6%. The Philadelphia Oil Service Sector index was posting a 0.7% increase, and the Dow Jones US Utilities index was up 0.2%. Front-month West Texas Intermediate crude oil declined...
Sector Update: Health Care
Sector Update: Health Care
Jul 30, 2024
03:39 PM EDT, 07/30/2024 (MT Newswires) -- Health care stocks edged up late Tuesday afternoon with the NYSE Health Care Index increasing 0.1% and the Health Care Select Sector SPDR Fund (XLV) fractionally higher. The iShares Biotechnology ETF (IBB) fell 0.1%. In corporate news, Imunon ( IMNN ) shares more than doubled after the company said topline data from a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved